Study of WAL0921 in Patients With Glomerular Kidney Diseases

Clinical trial NCT06466135 · RECRUITING

Trial details

NCT number: NCT06466135
Sponsor: Walden Biosciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathies Primary Focal Segmental Glomerulosclerosis Minimal Change Disease Primary Immunoglobulin A Nephropathy Primary Membranous Nephropathy

Start date: 2024-07-02
Primary completion: 2027-03-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.